ATE110962T1 - Srif-verwandte peptide und deren verwendungen. - Google Patents

Srif-verwandte peptide und deren verwendungen.

Info

Publication number
ATE110962T1
ATE110962T1 AT90909119T AT90909119T ATE110962T1 AT E110962 T1 ATE110962 T1 AT E110962T1 AT 90909119 T AT90909119 T AT 90909119T AT 90909119 T AT90909119 T AT 90909119T AT E110962 T1 ATE110962 T1 AT E110962T1
Authority
AT
Austria
Prior art keywords
srif
related peptides
administered
activity
compositions
Prior art date
Application number
AT90909119T
Other languages
English (en)
Inventor
Bernard Laarveld
Roy Neville Kirkwood
Philip Alfred Thacker
Lorraine M Sordillo
Mark Redmond
Original Assignee
Univ Saskatchewan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Saskatchewan filed Critical Univ Saskatchewan
Application granted granted Critical
Publication of ATE110962T1 publication Critical patent/ATE110962T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90909119T 1989-06-22 1990-06-21 Srif-verwandte peptide und deren verwendungen. ATE110962T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36949989A 1989-06-22 1989-06-22
US07/539,236 US5212156A (en) 1989-06-22 1990-06-18 Srif-related peptides and uses thereof

Publications (1)

Publication Number Publication Date
ATE110962T1 true ATE110962T1 (de) 1994-09-15

Family

ID=27004610

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90909119T ATE110962T1 (de) 1989-06-22 1990-06-21 Srif-verwandte peptide und deren verwendungen.

Country Status (10)

Country Link
US (1) US5212156A (de)
EP (1) EP0478609B1 (de)
JP (1) JPH05501858A (de)
CN (1) CN1048328A (de)
AT (1) ATE110962T1 (de)
AU (1) AU643444B2 (de)
CA (1) CA2059280A1 (de)
DE (1) DE69012328D1 (de)
IE (1) IE902274A1 (de)
WO (1) WO1990015618A2 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107014991A (zh) * 2017-03-29 2017-08-04 广东工业大学 一种生长抑素28肽多克隆抗体及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3845204A (en) * 1973-05-22 1974-10-29 American Home Prod Somatostatin as inhibiting agent in prolactin release
US3863008A (en) * 1973-06-11 1975-01-28 American Home Prod Somatostatin as stimulant of luteinizing hormone secretion
US3842066A (en) * 1973-06-25 1974-10-15 American Home Prod (aia3,aia14)-srif and intermediates
US3842067A (en) * 1973-07-27 1974-10-15 American Home Prod Synthesis of(des-asn5)-srif and intermediates
US3933784A (en) * 1975-01-27 1976-01-20 American Home Products Corporation Des-(ser13)-srif and intermediates
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides
US4812554A (en) * 1977-11-08 1989-03-14 Genentech, Inc. Somatostatin peptide conjugate
US4199500A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4244947A (en) * 1979-08-13 1981-01-13 Ayerst Mckenna And Harrison Inc. Carba decapeptide derivatives of [TYR6 ]-somatostatin
US4316891A (en) * 1980-06-14 1982-02-23 The Salk Institute For Biological Studies Extended N-terminal somatostatin
US4612302A (en) * 1983-11-14 1986-09-16 Brigham And Women's Hospital Clinical use of somatostatin analogues
US4569926A (en) * 1983-11-14 1986-02-11 Brigham And Women's Hospital Stimulation of phagocytosis with somatostatin
FR2638968B1 (fr) * 1988-11-11 1994-10-07 Sandoz Sa Nouvelle utilisation therapeutique de la somatostatine et de ses analogues et derives
DE3937539A1 (de) * 1988-11-11 1990-05-31 Sandoz Ag Lungenprotektivum

Also Published As

Publication number Publication date
JPH05501858A (ja) 1993-04-08
CN1048328A (zh) 1991-01-09
CA2059280A1 (en) 1990-12-23
IE902274L (en) 1990-12-22
AU5824490A (en) 1991-01-08
AU643444B2 (en) 1993-11-18
EP0478609B1 (de) 1994-09-07
WO1990015618A3 (en) 1991-02-21
DE69012328D1 (de) 1994-10-13
WO1990015618A2 (en) 1990-12-27
IE902274A1 (en) 1991-01-16
US5212156A (en) 1993-05-18
EP0478609A1 (de) 1992-04-08

Similar Documents

Publication Publication Date Title
GB2303855B (en) Helicobacter pylori antigenic protein preparation and immunoassays
ES2060603T3 (es) El uso de la proteina vp6 nucleocapsida de rotavirus en composiciones de vacunas.
KR960703942A (ko) 사람 융모막 고나도트로핀의 항원성을 갖는 화합물(Compounds having the antigenicity of hCG)
CA2103887A1 (en) Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
GR3029791T3 (en) Improved immunogenic compositions against human gastrin 17
CA2143823A1 (en) Retro-, inverso - and retro-inverso synthetic peptide analogues
BR9406652A (pt) Composição
AU4188789A (en) Urethane-protected amino acid-n-carboxyanhydrides
BR9500732B8 (pt) Kit diagnóstico para a detecção de anticorpos contra vírus que causam imunodeficiência.
AU2724492A (en) Antibodies in immunosuppression
GR3018691T3 (en) Amino acids, peptides or derivatives thereof coupled to fats
CA2019671A1 (en) Oxidative denaturation of protein analytes
SE9403526D0 (sv) New Peptides
DE3380629D1 (en) Region-specific determinants for vitamin k dependent bone protein
DK0383599T3 (da) Protein-anticancermiddel
ATE110962T1 (de) Srif-verwandte peptide und deren verwendungen.
WO1996002572A3 (fr) Sequence polypeptidique antigenique du facteur viii, fragments et/ou epitopes de celle-ci
AU7796291A (en) High affinity antibodies to small peptides
DK1612555T3 (da) Kryptiske peptider til anvendelse til at inducere immunologisk tolerance
GB2299994A (en) Equine arteritis virus peptides antibodies and their use in a diagnostic test
CA2071955A1 (en) Reduced-protein subunit vaccine for swine dysentery
AU525042B2 (en) Ovulation enhancing peptides
ATE87939T1 (de) Glycosylierte aminosaeuren und peptide.
AU639751B2 (en) Temporary minimal protection synthesis of lh-rh analogs
ITFI920071A1 (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties